4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-005126
General Counsel sold 26,381 shares at an average $6.08 ($160,457)
- General Counsel acquired 26,381 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
MOORE JOHN R · General Counsel
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-13 | Exercise or conversion : show line 1 in the form | +4,093 | $0.71 | $2,906 | 7,093 | D |
| 2022-06-13 | Sale : show line 2 in the form | −4,093 | $6.01 | $24,582 | 3,000 | D |
| 2022-06-14 | Exercise or conversion : show line 3 in the form | +3,628 | $0.71 | $2,576 | 6,628 | D |
| 2022-06-14 | Sale : show line 4 in the form | −3,628 | $6.02 | $21,855 | 3,000 | D |
| 2022-06-15 | Exercise or conversion : show line 5 in the form | +18,075 | $0.71 | $12,833 | 21,075 | D |
| 2022-06-15 | Exercise or conversion : show line 6 in the form | +585 | $1.93 | $1,129 | 21,660 | D |
| 2022-06-15 | Sale : show line 7 in the form | −585 | $6.11 | $3,575 | 21,075 | D |
| 2022-06-15 | Sale : show line 8 in the form | −18,075 | $6.11 | $110,445 | 3,000 | D |
| Open-market sales · 26,381 sh · avg $6.08 · $160,457 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-13 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −4,093 | 156,773 | D |
| 2022-06-14 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −3,628 | 153,145 | D |
| 2022-06-15 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −18,075 | 135,070 | D |
| 2022-06-15 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −585 | 196,336 | D |
Loading xslF345X03/primarydocument.xml…